This site uses cookies to store information on your computer. Learn more x

DSM in Medical

DSM partners with Sayan Orthopaedics Ltd. for the use of Dyneema Purity® fiber in innovative device for trauma treatment

Exton PA, US, 12 Mar 2014 15:15 CET

Dyneema Purity® fibers replace stainless steel in device for trauma treatment, designed for improving patient comfort, reducing potential allergic reactions and increasing flexibility during surgical implantation

DSM, a global leader in biomedical materials science and regenerative medicine, today announced a partnership with Sayan Orthopaedics Ltd. Sayan will use DSM’s Dyneema® Purity fiber in a trauma treatment device, having a combination of different types of Dyneema Purity ultra-high-molecular-weight polyethylene (UHMWPE) fiber only.

Sayan’s trauma device will use an UHMWPE braid made out of DSM’s Dyneema Purity fibers. With a fiber 15 times stronger than steel, the braid will be able to withstand high levels of force due to its strength and stiffness. Furthermore, the braid’s small diameter, high pliability and increased flexibility in combination with the device design, allows for easier adjustments during implantation. In addition to this the braid conforms to the shape of the bone, increasing the contact surface and lowering contact pressure. Patients are expected to experience increased comfort due to softness of Dyneema Purity fibers. The absence of  sharp edges may be expected to  minimize cutting into bone or soft tissue, which sometimes occurs with steel devices. Tissue inflammation and irritation are also minimized due to the fiber's biocompatibility and chemically inert properties. Additionally, using Dyneema Purity overcomes complications associated with metal allergies. 

DSM’s Dyneema Purity fiber is made at DSM’s Greenville, North Carolina USA facility, the only plant of its kind dedicated solely to the production of medical-grade UHMWPE fibers. Dyneema Purity materials have a proven track record for use in both short- and long-term orthopedic implants including treatments for damaged ACLs and high-strength orthopedic sutures.

This partnership will bring the first orthopedic trauma device using a combination of several Dyneema Purity fibers to the European market,” said Carola Hansen, Director of Biomedical Polyethylenes, DSM Biomedical. “Sayan Orthopaedics is one of the larger players in the trauma and orthopedics market in Turkey, and a developing player in the international arena in service of many multinationals worldwide. Our work with them supports DSM’s ongoing efforts to align with innovative companies from around the world.”

"We are very excited to announce our partnership with DSM,” said Serdar Omur Goren, Vice General Manager, Sayan Orthopaedics Ltd. “We chose Dyneema Purity fiber due to its high tensile strength and long, successful track record for use in medical implants.”

Sayan Orthopaedics Ltd. will communicate on the market rollout of the trauma device in European markets  later this year.